Last reviewed · How we verify

NCT06070935

Nailfold Capillaroscopic Assessment in Pediatric Uveitis Patients

Completed Last updated 15 August 2024
What this trial tests

trial in Uveitis in 46 participants. Completed in 30 June 2024.

Timeline
1 January 2024
Primary endpoint
30 May 2024
30 June 2024

Quick facts

Lead sponsorAssiut University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment46
Start date1 January 2024
Primary completion30 May 2024
Estimated completion30 June 2024
Sites1 location across Egypt

Conditions studied

Sponsor

Assiut University

Who can join

Under 18, any sex, with Uveitis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Pediatric uveitis accounts for 5-10% of uveitis cases. it may be infectious or noninfectious in etiology. The etiology of noninfectious uveitis may be autoimmune. The most common causes of pediatric uveitis are idiopathic and juvenile idiopathic arthritis-associated uveitis. Uveitis morbidities in pediatric patients include cataract, glaucoma, and amblyopia. Pediatric uveitis may be accopanied by involvement of the ocular vasculature, such as retinal vasculitis. We hypothesize that there are differences in systemic microcirculation between pediatric uveitis patients and healthy pediatric controls.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Uveitis

Currently open trials in the same condition.

Other Assiut University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06070935.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing